| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3865377 | The Journal of Urology | 2011 | 6 Pages |
Abstract
The intraprostatic injection of 100 or 300 units of onabotulinum toxin A passed predetermined criteria for treatment efficacy and safety, and a randomized trial with either dose is warranted. The 100 unit dose may be preferable due to similar efficacy with reduced costs and adverse effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
E. David Crawford, Kathryn Hirst, John W. Kusek, Robert F. Donnell, Steven A. Kaplan, Kevin T. McVary, Lance A. Mynderse, Claus G. Roehrborn, Christopher P. Smith, Reginald Bruskewitz,